FDA Approved Medical Products for:

Cerebellar ataxia and hypogonadotropic hypogonadism

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Recombinant human luteinizing hormone
Trade Name
(Manufacturer Name)
Luveris® (injection)
(EMD Serono, Inc.)
The FDA has approved this product to be used in this manner.
Luveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for stimulation of follicular development in infertile hypogonadotropic hypogonadal women with profound LH deficiency (LH (less than) 1.2 IU/L).
More Information about this product Drug Information Portal